Azithromycin induced hepatocellular toxicity and hepatic encephalopathy in asymptomatic dilated cardiomyopathy

Azithromycin is a widely used macrolide derivative and has generally been considered to be a very safe medication. Though gastrointestinal symptoms and reversible hearing loss are common, potentially serious side effects including angioedema and cholestatic jaundice occurred in less than one percent...

Descripción completa

Detalles Bibliográficos
Autor principal: Das, Bidyut Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229800/
https://www.ncbi.nlm.nih.gov/pubmed/22144789
http://dx.doi.org/10.4103/0253-7613.89841
_version_ 1782217994335682560
author Das, Bidyut Kumar
author_facet Das, Bidyut Kumar
author_sort Das, Bidyut Kumar
collection PubMed
description Azithromycin is a widely used macrolide derivative and has generally been considered to be a very safe medication. Though gastrointestinal symptoms and reversible hearing loss are common, potentially serious side effects including angioedema and cholestatic jaundice occurred in less than one percent of patients. We report a case of asymptomatic dilated cardiomyopathy with Azithromycin induced severe hepatocellular toxicity and hepatic encephalopathy.
format Online
Article
Text
id pubmed-3229800
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-32298002011-12-05 Azithromycin induced hepatocellular toxicity and hepatic encephalopathy in asymptomatic dilated cardiomyopathy Das, Bidyut Kumar Indian J Pharmacol Drug Watch Azithromycin is a widely used macrolide derivative and has generally been considered to be a very safe medication. Though gastrointestinal symptoms and reversible hearing loss are common, potentially serious side effects including angioedema and cholestatic jaundice occurred in less than one percent of patients. We report a case of asymptomatic dilated cardiomyopathy with Azithromycin induced severe hepatocellular toxicity and hepatic encephalopathy. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3229800/ /pubmed/22144789 http://dx.doi.org/10.4103/0253-7613.89841 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Drug Watch
Das, Bidyut Kumar
Azithromycin induced hepatocellular toxicity and hepatic encephalopathy in asymptomatic dilated cardiomyopathy
title Azithromycin induced hepatocellular toxicity and hepatic encephalopathy in asymptomatic dilated cardiomyopathy
title_full Azithromycin induced hepatocellular toxicity and hepatic encephalopathy in asymptomatic dilated cardiomyopathy
title_fullStr Azithromycin induced hepatocellular toxicity and hepatic encephalopathy in asymptomatic dilated cardiomyopathy
title_full_unstemmed Azithromycin induced hepatocellular toxicity and hepatic encephalopathy in asymptomatic dilated cardiomyopathy
title_short Azithromycin induced hepatocellular toxicity and hepatic encephalopathy in asymptomatic dilated cardiomyopathy
title_sort azithromycin induced hepatocellular toxicity and hepatic encephalopathy in asymptomatic dilated cardiomyopathy
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229800/
https://www.ncbi.nlm.nih.gov/pubmed/22144789
http://dx.doi.org/10.4103/0253-7613.89841
work_keys_str_mv AT dasbidyutkumar azithromycininducedhepatocellulartoxicityandhepaticencephalopathyinasymptomaticdilatedcardiomyopathy

Ejemplares similares